Infectious diseases continue to wreak havoc on people's health and health-care systems. Millions of people are affected by endemic diseases such chronic hepatitis, HIV, and other sexually transmitted infections, which exacerbate health inequities. Additional problems include health-care-associated and foodborne illnesses, both of which have been the focus of extensive prevention efforts, with some success in some regions, but with significant hurdles still ahead. Despite significant progress in reducing the burden of vaccine-preventable diseases, cases and outbreaks of these diseases continue to occur, owing to a variety of contributing factors. Emerging and re-emerging infections continue to pose a threat to prevention and control methods around the world, while the growing problem of antibiotic resistance requires immediate attention. Ensure that scientific and technological developments in molecular diagnostics and bioinformatics are adequately incorporated into public health is a top goal for infectious disease control.
Title : Novel nasal formulations containing EC16 to combat long COVID
Stephen Hsu, Augusta University, United States
Title : Selection underlying evolution and spread of SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Concept elicitation, cognitive debriefing and usability testing of COVID symptoms diary
Susan M Dallabrida, SPRIM US LLC, United States
Title : Insecticide resistance and use of household insecticides for personal protection: Insights from vector-borne disease outbreaks
Walter Fabricio Silva Martins, LSTM, United Kingdom
Title : Evaluating the effectiveness of antimicrobial stewardship on escherichia coli resistance in patients with urinary tract infection
Paulo Arroyo, Warwick Medical School, United Kingdom
Title : iiCON: Developing the infectious disease innovation ecosystem
Becky Jones-Phillips, Liverpool School of Tropical Medicine, United Kingdom